Summary
patients treated

Has anyone ever benefited from stem cell?

For the first time, umbilical cord blood cells were successfully used in 1988 in France. Several years later, in 2007, this method was also introduced by FamiCord Group in Poland. So far, umbilical cord blood stem cells have been transplanted over 40,000 times worldwide, saving peoples’ lives and health.

FamiCord Group enables their clients innovative treatment with stem cells. Check the full list of patients, suffered from diverse disorders, who benefited from it.

List of patients

List of patients
No.	Source	Source type	Diagnosis	Medical sector	Year of application	Therapy	Country	Age of the recipient
3601	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2019	Standard Therapy	Germany	26
3602	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2019	Standard Therapy	Germany	52
3603	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2019	Standard Therapy	Germany	38
3604	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2019	Standard Therapy	Germany	56
3605	Apheresis	Allogeneic	Acute Myeloid Leukemia – Relapse	Hematology	2019	Standard Therapy	Germany	51
3606	Apheresis	Autologous	Amyloidosis	Hematology	2019	Standard Therapy	Germany	60
3607	Apheresis	Allogeneic	Aplasia	Hematology	2019	Standard Therapy	Poland	51
3608	Apheresis	Allogeneic	Aplastic Anemia	Hematology	2019	Standard Therapy	Poland	16
3609	Apheresis	Allogeneic	B-Cell Acute Lymphoblastic Leukemia	Hematology	2019	Standard Therapy	Poland	8
3610	Apheresis	Allogeneic	B-Cell Acute Lymphoblastic Leukemia	Hematology	2019	Standard Therapy	Germany	46
3611	Apheresis	Allogeneic	B-Cell Acute Lymphoblastic Leukemia	Hematology	2019	Standard Therapy	Germany	21
3612	Apheresis	Allogeneic	B-Cell Acute Lymphoblastic Leukemia	Hematology	2019	Standard Therapy	Germany	28
3613	Apheresis	Allogeneic	B-Cell Chronic Lymphoblastic Leukemia	Hematology	2019	Standard Therapy	Poland	66
3614	Apheresis	Autologous	B-Cell Non-Hodgkin Lymphoma	Hematology	2019	Standard Therapy	Germany	66
3615	Apheresis	Allogeneic	Chronic Granulomatous Disease	Hematology	2019	Standard Therapy	Poland	2
3616	Apheresis	Allogeneic	Chronic Granulomatous Disease	Hematology	2019	Standard Therapy	Poland	16
3617	Apheresis	Allogeneic	Chronic Granulomatous Disease	Hematology	2019	Standard Therapy	Poland	3
3618	Apheresis	Allogeneic	Chronic Lymphocytic Leukemia	Hematology	2019	Standard Therapy	Poland	58
3619	Apheresis	Allogeneic	Chronic Lymphocytic Leukemia	Hematology	2019	Standard Therapy	Poland	65
3620	Apheresis	Allogeneic	Chronic Lymphocytic Leukemia	Hematology	2019	Standard Therapy	Poland	69
3621	Apheresis	Allogeneic	Chronic Lymphocytic Leukemia	Hematology	2019	Standard Therapy	Poland	65
3622	Apheresis	Allogeneic	Chronic Lymphocytic Leukemia	Hematology	2019	Standard Therapy	Poland	60
3623	Apheresis	Allogeneic	Chronic Lymphocytic Leukemia	Hematology	2019	Standard Therapy	Poland	69
3624	Apheresis	Allogeneic	Chronic Myelogenous Leukemia	Hematology	2019	Standard Therapy	Poland	23
3625	Apheresis	Allogeneic	Chronic Myelogenous Leukemia	Hematology	2019	Standard Therapy	Poland	34
3626	Apheresis	Allogeneic	Chronic Myelogenous Leukemia	Hematology	2019	Standard Therapy	Poland	37
3627	Apheresis	Allogeneic	Chronic Myelogenous Leukemia	Hematology	2019	Standard Therapy	Poland	56
3628	Apheresis	Allogeneic	Chronic Myelogenous Leukemia	Hematology	2019	Standard Therapy	Poland	58
3629	Apheresis	Allogeneic	Chronic Myelogenous Leukemia	Hematology	2019	Standard Therapy	Poland	56
3630	Apheresis	Allogeneic	Chronic Myelogenous Leukemia	Hematology	2019	Standard Therapy	Poland	31
3631	Apheresis	Allogeneic	Chronic Myelogenous Leukemia	Hematology	2019	Standard Therapy	Poland	54
3632	Apheresis	Allogeneic	Chronic Myelogenous Leukemia	Hematology	2019	Standard Therapy	Poland	46
3633	Apheresis	Allogeneic	Chronic Myelomonocytic Leukemia	Hematology	2019	Standard Therapy	Poland	54
3634	Apheresis	Allogeneic	Chronic Myelomonocytic Leukemia	Hematology	2019	Standard Therapy	Poland	65
3635	Apheresis	Allogeneic	Chronic Myelomonocytic Leukemia	Hematology	2019	Standard Therapy	Poland	73
3636	Apheresis	Allogeneic	Chronic Myelomonocytic Leukemia	Hematology	2019	Standard Therapy	Poland	62
3637	Apheresis	Autologous	Diffuse Large B-Cell Lymphoma	Hematology	2019	Standard Therapy	Germany	66
3638	Apheresis	Autologous	Embryonal Cell Carcinoma Of The Testicle	Hematology	2019	Standard Therapy	Germany	29
3639	Apheresis	Allogeneic	Extracranial Malignant Germ Cell Tumors	Hematology	2019	Standard Therapy	Poland	53
3640	Apheresis	Allogeneic	Glanzmann Thrombasthenia	Hematology	2019	Standard Therapy	Poland	11
3641	Apheresis	Allogeneic	High-Risk Myelodysplastic Syndrome	Hematology	2019	Standard Therapy	Poland	61
3642	Apheresis	Allogeneic	Histiocytosis X	Hematology	2019	Standard Therapy	Poland	14
3643	Apheresis	Allogeneic	Hodgkin Lymphoma	Hematology	2019	Standard Therapy	Poland	65
3644	Apheresis	Allogeneic	Hodgkin Lymphoma	Hematology	2019	Standard Therapy	Poland	58
3645	Apheresis	Allogeneic	Hodgkin Lymphoma	Hematology	2019	Standard Therapy	Poland	28
3646	Apheresis	Allogeneic	Hodgkin Lymphoma	Hematology	2019	Standard Therapy	Poland	44
3647	Apheresis	Allogeneic	Hodgkin Lymphoma	Hematology	2019	Standard Therapy	Poland	1
3648	Apheresis	Allogeneic	Hodgkin Lymphoma	Hematology	2019	Standard Therapy	Poland	32
3649	Apheresis	Allogeneic	Hodgkin Lymphoma	Hematology	2019	Standard Therapy	Poland	34
3650	Apheresis	Allogeneic	Mantle Cell Lymphoma	Hematology	2019	Standard Therapy	Poland	62
3651	Apheresis	Allogeneic	Mantle Cell Lymphoma	Hematology	2019	Standard Therapy	Poland	69
3652	Apheresis	Allogeneic	Mantle Cell Lymphoma	Hematology	2019	Standard Therapy	Poland	65
3653	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2019	Standard Therapy	Germany	66
3654	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2019	Standard Therapy	Germany	63
3655	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2019	Standard Therapy	Germany	59
3656	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2019	Standard Therapy	Germany	68
3657	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2019	Standard Therapy	Germany	65
3658	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2019	Standard Therapy	Germany	54
3659	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2019	Standard Therapy	Germany	64
3660	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2019	Standard Therapy	Germany	59
3661	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2019	Standard Therapy	Germany	59
3662	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2019	Standard Therapy	Germany	71
3663	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2019	Standard Therapy	Germany	63
3664	Apheresis	Allogeneic	Mixed Phenotype Acute Leukemia	Hematology	2019	Standard Therapy	Poland	59
3665	Apheresis	Allogeneic	Mixed Phenotype Acute Leukemia	Hematology	2019	Standard Therapy	Poland	49
3666	Apheresis	Autologous	Monoclonal Gammopathy Of Undetermined Significance-Sporadic Late Onset Nemaline Myopathy	Hematology	2019	Standard Therapy	Germany	36
3667	Apheresis	Autologous	Morbus Hodgkin	Hematology	2019	Standard Therapy	Germany	66
3668	Apheresis	Allogeneic	Mucopolysaccharidosis Type I	Metabolic	2019	Standard Therapy	Poland	1
3669	Apheresis	Allogeneic	Mucopolysaccharidosis Type Ii	Metabolic	2019	Standard Therapy	Poland	2
3670	Apheresis	Allogeneic	Mucopolysaccharidosis Type Ii	Metabolic	2019	Standard Therapy	Poland	2
3671	Apheresis	Allogeneic	Multiple Myeloma	Hematology	2019	Standard Therapy	Poland	52
3672	Apheresis	Allogeneic	Multiple Myeloma	Hematology	2019	Standard Therapy	Poland	55
3673	Apheresis	Autologous	Multiple Myeloma	Hematology	2019	Standard Therapy	Germany	68
3674	Apheresis	Autologous	Multiple Myeloma	Hematology	2019	Standard Therapy	Germany	58
3675	Apheresis	Autologous	Multiple Myeloma	Hematology	2019	Standard Therapy	Germany	58
3676	Apheresis	Autologous	Multiple Myeloma	Hematology	2019	Standard Therapy	Germany	69
3677	Apheresis	Autologous	Multiple Myeloma	Hematology	2019	Standard Therapy	Germany	58
3678	Apheresis	Autologous	Multiple Myeloma	Hematology	2019	Standard Therapy	Germany	65
3679	Apheresis	Autologous	Multiple Myeloma	Hematology	2019	Standard Therapy	Germany	52
3680	Apheresis	Autologous	Multiple Myeloma	Hematology	2019	Standard Therapy	Germany	56
3681	Apheresis	Autologous	Multiple Myeloma	Hematology	2019	Standard Therapy	Germany	54
3682	Apheresis	Autologous	Multiple Myeloma	Hematology	2019	Standard Therapy	Germany	51
3683	Apheresis	Autologous	Multiple Myeloma	Hematology	2019	Standard Therapy	Germany	57
3684	Apheresis	Autologous	Multiple Myeloma	Hematology	2019	Standard Therapy	Germany	52
3685	Apheresis	Autologous	Multiple Myeloma	Hematology	2019	Standard Therapy	Germany	61
3686	Apheresis	Autologous	Multiple Myeloma	Hematology	2019	Standard Therapy	Germany	68
3687	Apheresis	Autologous	Multiple Myeloma	Hematology	2019	Standard Therapy	Germany	59
3688	Apheresis	Autologous	Multiple Myeloma	Hematology	2019	Standard Therapy	Germany	64
3689	Apheresis	Autologous	Multiple Myeloma	Hematology	2019	Standard Therapy	Germany	39
3690	Apheresis	Autologous	Multiple Myeloma	Hematology	2019	Standard Therapy	Germany	52
3691	Apheresis	Autologous	Multiple Myeloma	Hematology	2019	Standard Therapy	Germany	59
3692	Apheresis	Autologous	Multiple Myeloma	Hematology	2019	Standard Therapy	Germany	63
3693	Apheresis	Autologous	Multiple Myeloma	Hematology	2019	Standard Therapy	Germany	40
3694	Apheresis	Autologous	Multiple Myeloma	Hematology	2019	Standard Therapy	Germany	57
3695	Apheresis	Autologous	Multiple Myeloma	Hematology	2019	Standard Therapy	Germany	53
3696	Apheresis	Autologous	Multiple Myeloma	Hematology	2019	Standard Therapy	Germany	64
3697	Apheresis	Autologous	Multiple Myeloma	Hematology	2019	Standard Therapy	Germany	70
3698	Apheresis	Autologous	Multiple Myeloma	Hematology	2019	Standard Therapy	Germany	68
3699	Apheresis	Autologous	Multiple Myeloma	Hematology	2019	Standard Therapy	Germany	56
3700	Apheresis	Autologous	Multiple Myeloma	Hematology	2019	Standard Therapy	Germany	63

Previous

Page 37 of 72 1 35 36 37 38 39 72

Next